Present and future of FDG-PET/CT in ovarian cancer

Kazuhiro Kitajima; Koji Murakami; Setsu Sakamoto; Yasushi Kaji; Kazuro Sugimura

doi:10.1007/s12149-010-0449-8

Present and future of FDG-PET/CT in ovarian cancer

Kazuhiro Kitajima, Koji Murakami, Setsu Sakamoto, Yasushi Kaji, Kazuro Sugimura

Department of Radiology

Research output: Contribution to journal › Review article › peer-review

31 Citations (Scopus)

Abstract

Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/ contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/ MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.

Original language	English
Pages (from-to)	155-164
Number of pages	10
Journal	Annals of Nuclear Medicine
Volume	25
Issue number	3
DOIs	https://doi.org/10.1007/s12149-010-0449-8
Publication status	Published - 2011 Apr 1

Keywords

FDG
Ovarian cancer
PET/CT
Restaging
Staging

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12149-010-0449-8

Cite this

@article{458ecb5a3cae426eb9c69d4ffc5b9674,

title = "Present and future of FDG-PET/CT in ovarian cancer",

abstract = "Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/ contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/ MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.",

keywords = "FDG, Ovarian cancer, PET/CT, Restaging, Staging",

author = "Kazuhiro Kitajima and Koji Murakami and Setsu Sakamoto and Yasushi Kaji and Kazuro Sugimura",

year = "2011",

month = apr,

day = "1",

doi = "10.1007/s12149-010-0449-8",

language = "English",

volume = "25",

pages = "155--164",

journal = "Annals of Nuclear Medicine",

issn = "0914-7187",

publisher = "Springer Japan",

number = "3",

}

TY - JOUR

T1 - Present and future of FDG-PET/CT in ovarian cancer

AU - Kitajima, Kazuhiro

AU - Murakami, Koji

AU - Sakamoto, Setsu

AU - Kaji, Yasushi

AU - Sugimura, Kazuro

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/ contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/ MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.

AB - Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/ contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/ MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.

KW - FDG

KW - Ovarian cancer

KW - PET/CT

KW - Restaging

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=79959992869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959992869&partnerID=8YFLogxK

U2 - 10.1007/s12149-010-0449-8

DO - 10.1007/s12149-010-0449-8

M3 - Review article

C2 - 21113691

AN - SCOPUS:79959992869

SN - 0914-7187

VL - 25

SP - 155

EP - 164

JO - Annals of Nuclear Medicine

JF - Annals of Nuclear Medicine

IS - 3

ER -

Present and future of FDG-PET/CT in ovarian cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this